THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

  • Trine Alma Knudsen (Lecturer)
  • Dennis Lund Hansen (Other)
  • Lucas Frans Ocias (Other)
  • Ole Weiss Bjerrum (Other)
  • Mette Brabrand (Other)
  • Christina Ellervik (Other)
  • Daniel el Fassi (Other)
  • Mikael Frederiksen (Other)
  • Lasse Kjær (Other)
  • Thomas Kielsgaard Kristensen (Other)
  • Kruse, T. A. (Guest lecturer)
  • Hans Torben Mourits-Andersen (Other)
  • Peter Møller (Other)
  • Ulrik Malthe Overgaard (Other)
  • Dustin Andersen Patel (Other)
  • Marianne Tang Severinsen (Other)
  • Vibe Skov (Other)
  • Anders Lindholm Sørensen (Other)
  • Stentoft Jesper (Other)
  • Jørn Starklint (Other)
  • Karin de Stricker (Other)
  • Thomassen, M. (Other)
  • Larsen, T. S. (Guest lecturer)
  • C Hasselbalc Hans (Other)

Activity: Talks and presentationsConference presentations

Period16. Jun 2019
Event title24th European Hematology Association Congress (EHA)
Event typeConference
LocationAmsterdam, Netherlands
Degree of RecognitionInternational